Thompson Matthew 4
4 · ENDOLOGIX INC /DE/ · Filed Aug 7, 2020
Insider Transaction Report
Form 4
Thompson Matthew
Chief Medical Officer
Transactions
- Disposition to Issuer
Common Stock
2020-08-05+30,433→ 78,183 total - Disposition to Issuer
Common Stock
2020-08-05$0.07/sh−3,417$239→ 74,766 total
Footnotes (2)
- [F1]This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on August 6, 2019. One-third of the shares subject to this restricted stock unit award vested pursuant to the terms of this award.
- [F2]Shares withheld on August 5, 2020 to satisfy statutory minimum tax withholding obligations related to shares vested on August 5, 2020.